Streetbeat News

Acquisitions Mergers

BTCUSD

The upcoming Bitcoin halving in April 2024 is expected to boost ETF opportunities in the cryptocurrency sector, according to a report by Canaccord Genuity. The halving, which reduces miner rewards by 50%, along with the approval of spot exchange-traded funds (ETFs) and a growing risk appetite, contributed to a 60% increase in Bitcoin's value in Q1 2024. The SEC's approval of 11 U.S. spot Bitcoin ETFs is seen as a positive development, potentially making spot ETFs a significant factor in Bitcoin's price action. However, the traditional impact of the halving may be diminishing due to the influx of institutional demand through Bitcoin ETFs.

Portfolio Pulse from Benzinga Neuro

March 28, 2024 | 12:17 pm

SYRA

Syra Health Corp. (NASDAQ:SYRA) has secured a statewide healthcare workforce contract in Missouri to provide temporary medical services personnel. The contract's revenue will depend on the number of positions filled and their duration, focusing on recruiting specialized medical professionals like resident physicians, physicians, chief physicians, psychiatrists, and chief psychiatrists. This expansion into Missouri marks the 18th state where Syra Health has established a presence, emphasizing its commitment to enhancing healthcare delivery nationwide.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:11 pm

RGP

Resources Connection, Inc. (RGP) has announced its intention to acquire Reference Point, a strategic consultancy firm. The financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:07 pm

LH

OPK

Labcorp (NYSE:LH) is set to acquire select assets of BioReference Health, a subsidiary of OPKO Health (NASDAQ:OPK), for $237.5M. This acquisition aims to enhance Labcorp's laboratory services network and expand access to high-quality clinical laboratory services across the US, excluding New York and New Jersey. The transaction, expected to close in the second half of 2024, will include patient service centers and certain customer contracts. BioReference Health will retain its oncology and urology diagnostic services and continue full operations in New York and New Jersey. The assets being acquired generate about $100 million in annual revenue.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 12:06 pm

AAPL

Gene Munster of Deepwater Asset Management predicts Apple Inc.'s WWDC 2024 will introduce significant changes in operating system design with a focus on generative AI, marking the most substantial shift since the 1980s. This includes potential upgrades to core apps and Siri. However, Munster notes Apple is playing catch-up in the generative AI space, with competitors like Microsoft and Google already advancing. Apple's recent acquisition of DarwinAI and possible licensing of Google's Gemini AI for iOS 18 suggest a major push into AI.

Portfolio Pulse from Rounak Jain

March 28, 2024 | 11:58 am

GILD

XLO

Xilio Therapeutics' stock price increased following the announcement of an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. Additionally, Xilio announced an $11.3 million private placement equity financing.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:41 am

ISPR

RGF

The article highlights Ispire Technology Inc. (ISPR) and The Real Good Food Company, Inc. (RGF) as the top 2 defensive stocks in the consumer staples sector, considered undervalued due to their low RSI values. ISPR announced a public offering, causing a stock price drop, while RGF appointed a new CEO and faced a downgrade by B. Riley Securities.

Portfolio Pulse from Avi Kapoor

March 28, 2024 | 11:35 am

GCTS

GCT Semiconductor shares are trading lower due to volatility after completing a business combination with Concord Acquisition Corp III and debuting on the NYSE.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:26 am

ALLY

DFS

NUMV

RDIV

Ally Financial Inc has announced Michael G. Rhodes as its new CEO, effective April 29, 2024. Rhodes, previously CEO at Discover Financial Services, replaces Jeffrey J. Brown. Discover Financial has appointed J. Michael Shepherd as Interim CEO following Rhodes' departure. Investors can gain exposure to ALLY through ETFs like RDIV and NUMV. ALLY shares saw a slight decrease in premarket trading.

Portfolio Pulse from Lekha Gupta

March 28, 2024 | 11:21 am

ATLX

Atlas Lithium's stock price increased following the announcement of a $30 million investment and offtake agreement with Mitsui & Co.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 11:14 am